TwinStrand Bio is leading the way in identifying ultra-low frequency genomic variants that are undetectable by conventional NGS methods. Our highly sensitive and specific Duplex Sequencing technology delivers clearer insights to researchers and clinicians in applications ranging from residual cancer detection to genetic toxicology. This data can inform critical decisions in clinical medicine, public health, and other fields of science on a faster timescale when actions are most impactful.